10-Q: TruBridge Inc. Reports Q1 2024 Results: Revenue Declines Amid Strategic Shift, Net Loss Reported

TruBridge Inc. experienced a 3% decrease in revenue and a net loss in the first quarter of 2024, driven by a decline in EHR revenue and increased expenses, despite growth in RCM.

Summary

• TruBridge Inc. reported a 3% decrease in total revenue for the first quarter of 2024, with revenues totaling $83.2 million compared to $86.2 million in the same period last year.
• The company experienced a net loss of $2.5 million, a significant decrease from the $3.1 million net income reported in the first quarter of 2023.
• Revenue Cycle Management (RCM) revenue increased by 9% to $53.0 million, driven by the acquisition of Viewgol, which contributed $4.7 million in revenue.
• Electronic Health Records (EHR) revenue decreased by 20% to $28.0 million, primarily due to a decline in recurring revenue and the sale of American HealthTech, Inc.
• Patient Engagement revenue decreased by 9% to $2.2 million due to the timing of annual license renewals.
• The company's effective tax rate increased to 39.4% from 20.8% due to the gain on the sale of American HealthTech, Inc. and the impact of the research and development tax credit.
• Adjusted EBITDA decreased to $9.5 million from $14.6 million in the prior year period.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive aspects like RCM growth and a focus on recurring revenue, but the overall sentiment is negative due to decreased revenue, a net loss, and declining profitability. The company is facing challenges in its EHR segment and is undergoing a strategic shift, which adds uncertainty.

Positives

• RCM revenue increased by 9% year-over-year, driven by the acquisition of Viewgol.
• The company has a strong recurring revenue base in RCM, with 97.5% of RCM revenue being recurring.
• The company is focused on margin optimization through organizational realignment, expanded use of offshore resources, and automation.
• The company has a twelve-month backlog of approximately $321 million in connection with recurring payments under support and maintenance and RCM services.

Negatives

• Total revenue decreased by 3% year-over-year.
• The company reported a net loss of $2.5 million, a significant decrease from the $3.1 million net income in the same quarter last year.
• EHR revenue decreased by 20%, impacted by the sale of American HealthTech, Inc. and a shift towards SaaS licensing.
• Adjusted EBITDA decreased by 35% to $9.5 million.
• The company experienced increased severance costs, non-recurring charges, and interest expenses.
• The company's effective tax rate increased to 39.4%.

Risks

• The company faces risks related to market saturation, hospital consolidations, and unfavorable economic conditions.
• The transition to a subscription-based recurring revenue model and modernization of technology pose challenges.
• The company faces competition from companies with greater financial and technical resources.
• Potential future acquisitions may be expensive and time-consuming.
• The company's operations could be disrupted by the implementation of a new enterprise resource planning software solution.
• The company is exposed to numerous and often conflicting laws, regulations, policies, and standards through its international business activities.
• The company faces potential litigation and investigations.
• The company's substantial indebtedness may adversely affect its business operations.
• The company's stock price may be volatile.
• The company's Rights Agreement could discourage a takeover or other transaction that stockholders may consider favorable.

Future Outlook

The company expects the trend of customers shifting towards SaaS license models to continue, which will impact short-term revenue growth and profitability but benefit long-term revenue growth and profitability. The company also anticipates incremental margin pressure from the continued client transition from perpetual license arrangements to Software as a Service (SaaS) arrangements.

Management Comments

• Management believes adjusted EBITDA is a useful measure to assess the performance and liquidity of the Company as it provides meaningful operating results by excluding the effects of expenses that are not reflective of its operating business performance.
• Management is focused on achieving meaningful long-term revenue growth by cross-selling RCM services into its existing EHR customer base, expanding RCM market share with sales to new community hospitals and larger health systems, and pursuing competitive EHR takeaway opportunities in the acute care markets.
• Management believes that the company's efforts towards margin optimization are well-timed, enabling a rapid response to actual or expected wage inflation in order to preserve RCM gross margins.

Industry Context

The healthcare industry is experiencing increasing pressure to reduce costs and increase quality, which is driving the adoption of healthcare IT and increasing demand for business management, consulting, and managed IT services. The shift towards value-based reimbursement is also impacting healthcare providers, encouraging them to adopt technology solutions that improve patient engagement and care coordination.

Comparison to Industry Standards

• The company's shift towards SaaS licensing is consistent with industry trends, where healthcare providers are increasingly seeking subscription-based models to reduce upfront capital expenditures.
• The company's focus on RCM services aligns with the growing demand for outsourced revenue cycle management solutions in the healthcare industry.
• The company's customer retention rates in the mid-to-high 90th percentile range are generally considered strong within the healthcare IT industry, although the recent annualized rate of 91.1% is a decrease.
• The company's adjusted EBITDA margin of 11.4% is lower than some of its peers in the healthcare IT sector, which may indicate a need for further cost optimization efforts.
• The company's revenue growth of -3% is below the average growth rate for the healthcare IT industry, which is estimated to be in the mid-single digits.

Corporate Governance

Stakeholder Impact

• Shareholders may be concerned about the company's decreased revenue, net loss, and declining profitability.
• Employees may be affected by the company's organizational realignment and cost containment measures.
• Customers may benefit from the company's focus on improving the health of the communities it serves and improving the financial operations of its customers.
• Creditors may be concerned about the company's substantial indebtedness and its ability to comply with the terms of its credit agreement.

Next Steps

• The company will continue to focus on cross-selling RCM services to its existing EHR customer base.
• The company will continue to expand its RCM market share with sales to new community hospitals and larger health systems.
• The company will pursue competitive EHR takeaway opportunities in the acute care markets.
• The company will continue to implement its margin optimization initiatives.
• The company will continue to monitor the impact of the shift towards SaaS licensing on its financial results.

Key Dates

Keywords

Revenue Cycle Management, Electronic Health Records, Healthcare IT, SaaS, Recurring Revenue, Community Hospitals, Patient Engagement, EBITDA, Acquisition, Software Licenses